Image de couverture de livre

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Tianyu Zhan
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Group sequential designs for clinical trials when the maximum sample size is uncertain
par: Amin Yarahmadi, et autres
Publié: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
par: Wenhao Cao, et autres
Publié: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
par: James A. Salsbury, et autres
Publié: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
par: Yunfei Wang
Publié: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
par: Yu Du, et autres
Publié: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
par: Luana Boumendil, et autres
Publié: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
par: Jialu Fang, et autres
Publié: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
par: Peiran Liu, et autres
Publié: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
par: Ilya Lipkovich, et autres
Publié: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
par: Holly Hartman, et autres
Publié: (2024)

Use of win time for ordered composite endpoints in clinical trials
par: James F. Troendle, et autres
Publié: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
par: Ian C. Marschner
Publié: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
par: Shuxi Zeng, et autres
Publié: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
par: Stephen Schüürhuis, et autres
Publié: (2024)

An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
par: Tianyu Zhan, et autres
Publié: (2025)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
par: Jonathan C. Moyer, et autres
Publié: (2024)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
par: Yichen Yan, et autres
Publié: (2025)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
par: Tianyu Zhan, et autres
Publié: (2026)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
par: Matthias Kormaksson, et autres
Publié: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
par: Carly Lupton Brantner, et autres
Publié: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
par: Johannes Krisam, et autres
Publié: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
par: Edward L. Korn, et autres
Publié: (2024)

Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
par: Jaehyun Seo, et autres
Publié: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
par: Xiaosong Shi, et autres
Publié: (2024)

Comparing two hazard curves when there is a treatment time‐lag effect
par: Xiaoxi Zhang, et autres
Publié: (2024)

Beyond the two‐trials rule
par: Leonhard Held
Publié: (2024)

Sample size calculation for comparing two screening tests when the gold standard is missing at random
par: Yougui Wu
Publié: (2024)

Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations
par: Kenneth Menglin Lee, et autres
Publié: (2024)

Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
par: Benjamin F. Hartley, et autres
Publié: (2025)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
par: Samuel K Sarkodie, et autres
Publié: (2024)

A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
par: Zoë S. Dunias, et autres
Publié: (2024)

Robust analysis of stepped wedge trials using composite likelihood models
par: Emily C. Voldal, et autres
Publié: (2024)

Modeling intra‐individual inter‐trial EEG response variability in autism
par: Mingfei Dong, et autres
Publié: (2024)

Determining sample size in a personalized randomized controlled (PRACTical) trial
par: Rebecca M. Turner, et autres
Publié: (2024)

Integrative deep learning with prior assisted feature selection
par: Feifei Wang, et autres
Publié: (2024)

Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
par: Zifei Han, et autres
Publié: (2025)

Approximate balancing weights for clustered observational study designs
par: Eli Ben‐Michael, et autres
Publié: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
par: Shiwei Cao, et autres
Publié: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
par: Dustin J. Rabideau, et autres
Publié: (2024)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
par: Thomas Burnett, et autres
Publié: (2024)